吉利德科学公司 (Gilead Sciences) 向 Arcus Biosciences 投资 3.2 亿美元，将持股比例增加至 33%，并修改了合作协议，吉利德科学公司 (Gilead Sciences) 的 CCO 加入了 Arcus 董事会。 Gilead Sciences invests $320M in Arcus Biosciences, increasing ownership to 33%, and amends collaboration agreement, with Gilead's CCO joining Arcus's board.
吉利德科学公司 (Gilead Sciences) 向 Arcus Biosciences 投资 3.2 亿美元，将其在该公司的持股比例增至 33%。 Gilead Sciences has invested $320 million in Arcus Biosciences, increasing its ownership stake in the company to 33%. 这项投资以及对合作协议的修订将加速两家公司跨多个适应症的联合开发计划的发展。 This investment, along with amendments to their collaboration agreement, will accelerate the growth of the companies' joint development programs across multiple indications. 此外，吉利德首席商务官将加入 Arcus 董事会。 Additionally, Gilead's Chief Commercial Officer will join Arcus's board.